The Evaluation of Gemcitabine in Resistant or Relapsing Multiple Myeloma, Phase II: a Southwest Oncology Group Study
Year: 2002
Type: article
Study design: Clinical Trial
Source: Investigational New Drugs
Authors: James K. Weick, John J. Crowley, Mohamed A. Hussein, Dennis F. Moore, Bart Barlogie
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: Southwest Oncology Group, G1202672505, G1205502904, G1331445602, Columbus Community Clinical Oncology Program (Columbus CCOP), G1469275664, G1646027999, G1911575068, G2064543036, G2160369479, G2562936776, G268786457, G2745671310, COLUMBIA UNIVERSITY SOUTHWEST ONCOLOGY GROUP PROGRAM, G2780474162, Southwest Oncology Group U10 Member Site, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3041257426, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3334379738, G413878341, Southwest Oncology Group, G425646771, G4292856267, G5125348268, SOUTHWEST ONCOLOGY GROUP CA13612, G5653597704, COMMUNITY CLINICAL ONCOLOGY PROGRAM, SOUTHWEST ONCOLOGY GROUP--COOP GROUP CLINICAL STUDY, G6109875642, Southwest Oncology Group Treatment Grant, Atlanta Regional Community Clinical Oncology Program (ARCCOP), SOUTHWEST ONCOLOGY GROUP, SOUTHWEST ONCOLOGY GROUP STUDIES, University of Colorado Southwest Oncology Group, NORTHWEST COMMUNITY CLINICAL ONCOLOGY PROGRAM, G712978930, SOUTHWEST ONCOLOGY GROUP STUDY, Community Clinical Oncology Program, G758084519, G763325562, Western Regional Community Clinical Oncology Program, Kansas City Clincal Oncology Program CCOP, ST Louis-Cape Girardeau CCOP, SOUTHWEST ONCOLOGY GROUP (UTAH), SOUTHWEST ONCOLOGY GROUP
OpenAlex ID: W46241239